Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Year-end report 2023: Scientific and regulatory progress generating international interest | ||||||||||
By: PR Newswire Association LLC. - 16 Feb 2024 | Back to overview list |
|||||||||
LUND, Sweden, Feb. 16, 2024 /PRNewswire/ --
Comment from the CEO "It is with mixed feelings that we sum up 2023. Of course, we would have liked to see a better financial performance for the company, but it is gratifying that sales in Sweden were up by 31 percent. Last fall, we saw fantastic results from independent research studies that together with the coming MDR certification pave the way for a very exciting future. Order intake from our major partners has been disappointing in recent years, but I am confident that it will pick up once MDR certification and clinical outcomes are in place. Coupled with our efforts to establish collaborations with new partners and enter new markets, this will provide Enzymatica with good growth in the coming years", said Claus Egstrand, CEO. Significant events during the quarter
Significant events after the quarter
Other events during and after the quarter
The full report is available on: www.enzymatica.com/investors/financial-reports This information is information that Enzymatica is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CET on February 16, 2024. For more information, please contact: Claus Egstrand, Chief Executive Officer, Enzymatica AB Stefan Olsson, Communication Manager, Enzymatica AB Enzymatica AB is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market. The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/year-end-report-2023-scientific-and-regulatory-progress-generating-international-interest-302063922.html |
||||||||||
|
||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |